Global /China /Industrials /Specialty Business Services /2268

WuXi XDC Cayman Inc.

2268

• SHEK: 2268 • Delayed

58.90HKD 0.6%

7.52 USD

As of 5 June 2026, WuXi XDC Cayman Inc. has a market cap of $9.42B USD, ranking #2327 globally and #367 in China. It ranks #458 in the Industrials sector, and #29 in the Specialty Business Services industry.

Global Rank

2327

Country Rank

367

Sector Rank

458

Industry Rank

Key Stats

Market Cap

$9.42BUSD

73.79B HKD

Enterprise Value

$8.48BUSD

66.46B HKD

Revenue (TTM)

$844.03MUSD

6.61B HKD

EBITDA (TTM)

$250.84MUSD

1.97B HKD

Net Income (TTM)

$210.22MUSD

1.65B HKD

EBITDA Margin

30%

Profit Margin

25%

PE Ratio

47.0

Forward PE

31.3

PS Ratio

11.2

PB Ratio

6.2

EV/EBITDA

33.8

Company Profile

Country (HQ)

China

Sector

Industrials

Industry

Specialty Business Services

CEO

Jincai Li open_in_new

Employees

2,662

Founded

2013

Website

wuxixdc.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.6%	-1.3%	-0.6%	-10%	-20%	-3.6%	58%	87%	87%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	2268 藥明合聯生物技術有限公司 ISIN: KYG9808A1058 Shares Out.: Shares Outstanding: 1.261B¹ Shares Float: 358.751M² TV: TradingView: HKEX: 2268 SA: Stock Analysis: HKG: 2268 YF: Yahoo Finance: 2268.HK GF: Google Finance: HKG: 2268 BA: Barron's: 2268 MS: Morningstar: XHKG: 02268	58.90 HKD	TV: TradingView: HKEX: 2268 SA: Stock Analysis: HKG: 2268 YF: Yahoo Finance: 2268.HK GF: Google Finance: HKG: 2268 BA: Barron's: 2268 MS: Morningstar: XHKG: 02268

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About WuXi XDC Cayman Inc.

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services. Additionally, the company engages in the research and development, manufacturing, and marketing of anti-tumor drugs WuXi XDC Cayman Inc. has a strategic collaboration with Earendil Labs. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.

Similar Companies

Industry: Specialty Business Services (China)

Name	Market Cap (USD) diff.	PE	Country
Beijing Compass Technology Development Co., Ltd. SHE: 300803	$8.77B 59.36B CNY -6.8%	296.1	China
TAL Education Group NYSE: TAL	$6.6B -30%	11.8	China
Hui Lyu Ecological Technology Groups Co.,Ltd. SHE: 001267	$6.26B 42.34B CNY -34%	480.6	China
Jiangsu Boqian New Materials Stock Co., Ltd. SSE: 605376	$4.62B 31.29B CNY -51%	128.4	China
Suzhou Tianmai Thermal Technology Co., Ltd. SHE: 301626	$4.6B 31.16B CNY -51%	163.3	China
Shenzhen Fortune Trend Technology Co., Ltd. SSE: 688318	$4.17B 28.24B CNY -56%	89.6	China

Industry: Specialty Business Services (Global)

Name	Market Cap (USD) diff.	PE	Country
Shopify Inc. NASDAQ: SHOP	$158.14B 2K%	129.8	Canada
Verisure plc STO: VSURE	$133.15B 114.8B EUR 1K%	-	United Kingdom
Cintas Corp. NASDAQ: CTAS	$69.6B 639%	36.8	United States
RELX PLC LSE: REL	$63.87B 47.6B GBP 578%	23.9	United Kingdom
PayPal Holdings, Inc. NASDAQ: PYPL	$45.83B 387%	9.4	United States
T Thomson Reuters Corp. NEO: TRI	$41.8B 56.91B CAD 344%	-	Canada

chevron_leftBack